Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 14, 2006; 12(38): 6167-6171
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6167
Abnormalities of uterine cervix in women with inflammatory bowel disease
Jyoti Bhatia, Jason Bratcher, Burton Korelitz, Katherine Vakher, Shlomo Mannor, Maria Shevchuk, Gworgia Panagopoulos, Adam Ofer, Ecaterina Tamas, Panayota Kotsali, Oana Vele
Jyoti Bhatia, Jason Bratcher, Burton Korelitz, Katherine Vakher, Shlomo Mannor, Maria Shevchuk, Gworgia Panagopoulos, Adam Ofer, Ecaterina Tamas, Panayota Kotsali, Oana Vele, Division of Gastroenterology, Department of Medicine and Departments of Obstetrics and Gynecology and Pathology Lenox Hill Hospital and New York University School of Medicine, New York, United States
Correspondence to: Jason M Bratcher, Division of Gastroenterology, Department of Medicine and Departments of Obstetrics and Gynecology and Pathology Lenox Hill Hospital and New York University School of Medicine, New York, United States. jasonbratcher@msn.com
Telephone: +1-212-4342000 Fax: +1-212-4343396
Received: July 3, 2006
Revised: July 8, 2006
Accepted: July 14, 2006
Published online: October 14, 2006
Abstract

AIM: To evaluate the prevalence of abnormalities of the uterine cervix in women with inflammatory bowel disease (IBD) when compared to healthy controls.

METHODS: One hundred and sixteen patients with IBD [64 with Crohn’s disease (CD) and 52 with ulcerative colitis (UC)] were matched to 116 healthy controls by age (+/- 2 years) at the time of most recent papanicolaou (Pap) smear. Data collected consisted of age, race, marital status, number of pregnancies, abortions/miscarriages, duration and severity of IBD, Pap smear results within five years of enrollment, and treatment with immunosuppressive drugs. Pap smear results were categorized as normal or abnormal including atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LGSIL), and high-grade squamous intraepithelial lesion (HGSIL).

RESULTS: The median age at the time of Pap smear was 46 (range: 17-74) years for the IBD group and matched controls (range: 19-72 years). There were more Caucasian subjects than other ethnicities in the IBD patient group (P = 0.025), as well as fewer abortions (P = 0.008), but there was no significant difference regarding marital status. Eighteen percent of IBD patients had abnormal Pap smears compared to 5% of controls (P = 0.004). Subgroup analysis of the IBD patients revealed no significant differences between CD and UC patients in age, ethnicity, marital status, number of abortions, disease severity, family history of IBD, or disease duration. No significant difference was observed in the number of abnormal Pap smears or the use of immunosuppressive medications between CD and UC patients (P = 0.793). No definitive observation could be made regarding HPV status, as this was not routinely investigated during the timeframe of our study.

CONCLUSION: Diagnosis of IBD in women is related to an increased risk of abnormal Pap smear, while type of IBD and exposure to immunosuppressive medications are not. This has significant implications for women with IBD in that Pap smear screening protocols should be conscientiously followed, with appropriate investigation of abnormal results.

Keywords: Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Cervical cancer; Pap smear